STL Volume 16 Number 10

Update on drugs, approval dates, and comments. Belimumab (Benlysta™), Tolnaftate 1% Cream (Tolnaftate-D™), Hydrocortisone 1% Cream (Hydrocortisone-D™), Ketoconazole 2% Foam are covered.

Patient adherence remains a serious challenge with acne patients. This article will review this problem and offer a number of suggestions, including dosing considerations and the use of laser/light devices, to better treat the non-adherent patient.

Since the elucidation of the concept of selective photothermolysis, quality-switched lasers have been the gold standard for tattoo removal. This article reviews appropriate device selection and technique, and the importance of patient education.